Insider trades
Kory James Wentworth, CFO of Entrada Therapeutics TRDA, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $433.6K. The latest trade was on 04/01.
Kory James Wentworth
CFO
- Company
- Entrada Therapeutics TRDA
- First filing
- 23/03/03
- Trades
- 74 trades
- Buys / sales
- 0 / 24
- 12-month net buying
- −$433.6K
- Last trade
- 04/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 04/01 | 04/02 | 2,500 sh | $12.95 | $32,375 | −2.1% | |
| Open-market sale10b5-1 plan | 03/09–03/10 | 03/11 | 16,477 sh2 trades | $13.01avg. | $214,428.76 | −11.9% | |
| Open-market sale10b5-1 plan | 03/04 | 03/06 | 7,988 sh | $12.25 | $97,853 | −5.5% | |
| Open-market sale10b5-1 plan | 25/11/21 | 25/11/24 | 8,910 sh | $9.98 | $88,921.8 | −7.5% | |
| Open-market sale10b5-1 plan | 25/03/17 | 25/03/19 | 1,784 sh | $10.67 | $19,035.28 | −1.6% | |
| Open-market sale10b5-1 plan | 24/11/29–24/12/02 | 24/12/03 | 6,000 sh2 trades | $20.00avg. | $119,970 | −7.5% | |
| Open-market sale10b5-1 plan | 24/11/11 | 24/11/13 | 8,637 sh | $19.98 | $172,567.26 | −10.5% | |
| Open-market sale10b5-1 plan | 24/09/09 | 24/09/10 | 3,195 sh | $14.97 | $47,829.15 | −4.0% | |
| Open-market sale10b5-1 plan | 24/07/08 | 24/07/10 | 1,758 sh | $14.95 | $26,282.1 | −2.1% | |
| Open-market sale10b5-1 plan | 24/03/06 | 24/03/08 | 4,086 sh | $12.31 | $50,298.66 | −5.2% | |
| Open-market sale10b5-1 plan | 23/12/21–23/12/26 | 23/12/26 | 12,500 sh4 trades | $15.59avg. | $194,819.9 | −20.1% | |
| Open-market sale10b5-1 plan | 23/09/06 | 23/09/06 | 950 sh2 trades | $13.48avg. | $12,804.18 | −1.9% | |
| Open-market sale10b5-1 plan | 23/07/10–23/07/11 | 23/07/12 | 10,000 sh2 trades | $17.99avg. | $179,877.68 | −21.4% | |
| Open-market sale10b5-1 plan | 23/06/21 | 23/06/23 | 17,500 sh2 trades | $15.01avg. | $262,639.31 | −38.5% | |
| Open-market sale | 23/03/02 | 23/03/03 | 1,747 sh2 trades | $10.52avg. | $18,385.27 | −4.0% |